COVID-19 : An Alert to Ventilator-Associated Bacterial Pneumonia
This manuscript aims to highlight the risk of Ventilator-Associated Bacterial Pneumonia (VAP) in COVID-19 inpatients. The co-infection has the potential to worsen clinical condition and increase mortality in these patients, as well as to prolong and increase the costs of hospitalization. Preventing, identifying and treating early VAP can increase the chances of successful treatment in patients with COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Infectious diseases and therapy - 9(2020), 3 vom: 30. Sept., Seite 417-420 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Póvoa, Helvécio Cardoso Corrêa [VerfasserIn] |
---|
Links: |
---|
Themen: |
Co-infection |
---|
Anmerkungen: |
Date Revised 27.11.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1007/s40121-020-00306-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM310553342 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM310553342 | ||
003 | DE-627 | ||
005 | 20231225140340.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s40121-020-00306-5 |2 doi | |
028 | 5 | 2 | |a pubmed24n1035.xml |
035 | |a (DE-627)NLM310553342 | ||
035 | |a (NLM)32474891 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Póvoa, Helvécio Cardoso Corrêa |e verfasserin |4 aut | |
245 | 1 | 0 | |a COVID-19 |b An Alert to Ventilator-Associated Bacterial Pneumonia |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 27.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a This manuscript aims to highlight the risk of Ventilator-Associated Bacterial Pneumonia (VAP) in COVID-19 inpatients. The co-infection has the potential to worsen clinical condition and increase mortality in these patients, as well as to prolong and increase the costs of hospitalization. Preventing, identifying and treating early VAP can increase the chances of successful treatment in patients with COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Co-infection | |
650 | 4 | |a Coronavirus | |
650 | 4 | |a Covid-19 | |
650 | 4 | |a Microorganisms | |
650 | 4 | |a Sars-CoV-2 | |
650 | 4 | |a Secondary infection | |
650 | 4 | |a Ventilator-associated pneumonia | |
700 | 1 | |a Chianca, Gabriela Ceccon |e verfasserin |4 aut | |
700 | 1 | |a Iorio, Natalia Lopes Pontes Póvoa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Infectious diseases and therapy |d 2012 |g 9(2020), 3 vom: 30. Sept., Seite 417-420 |w (DE-627)NLM240483693 |x 2193-8229 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2020 |g number:3 |g day:30 |g month:09 |g pages:417-420 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40121-020-00306-5 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2020 |e 3 |b 30 |c 09 |h 417-420 |